Efficacy and Safety of Osilodrostat in Paraneoplastic Cushing Syndrome: A Real-World Multicenter Study in France.
Dormoy A, Haissaguerre M, Vitellius G, Do Cao C, Geslot A, Drui D, Lasolle H, Vieira-Pinto O, Salenave S, François M, Puerto M, Boullay HD, Mayer A, Rod A, Laurent C, Chanson P, Reznik Y, Castinetti F, Chabre O, Baudin E, Raverot G, Tabarin A, Young J.
J Clin Endocrinol Metab. 2023 May 17;108(6):1475-1487. doi: 10.1210/clinem/dgac691.
PMID:36470583
Hypokalemia associated with mifepristone use in the treatment of Cushing's syndrome.
Sai K, Lal A, Lakshmi Maradana J, Velamala PR, Nitin T.
Endocrinol Diabetes Metab Case Rep. 2019 Nov 12;2019:19-0064. doi: 10.1530/EDM-19-0064. Online ahead of print.
PMID:31743097
Association of hypertension and hypokalemia with Cushing's syndrome caused by ectopic ACTH secretion: a series of 58 cases.
Torpy DJ, Mullen N, Ilias I, Nieman LK.
Ann N Y Acad Sci. 2002 Sep;970:134-44. doi: 10.1111/j.1749-6632.2002.tb04419.x.